Rare diseases
Investigational molecules
Locations
1 Evertrust Plaza Floor 13th, 07302-3051, United States
Scynexis Inc. focuses its clinical research on serious fungal infections, with particular attention to invasive candidiasis and candidemia. The company’s trial activity centers on treatment strategies for bloodstream and deep-seated Candida infections in adult patients.
Research in this area reflects interest in managing complex infections that require sequential intravenous and oral antifungal treatment approaches.
Scynexis Inc. runs clinical trials in conditions such as Systemic candida, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
